209: Implementation of MRSA Nasal Swabs to Decrease Anti-MRSA Therapy in COVID-19 Infection
Emily Johnston(Our Lady of the Lake Regional Medical Center), Christopher Thomas(Louisiana State University Health Sciences Center New Orleans), Alaina DeKerlegand(Methodist University Hospital), Britney Ross(Our Lady of the Lake Regional Medical Center), Catherine O’Neal(Louisiana State Department of Health and Hospitals)
Cited by 0
Related Papers
<i>Vital Signs:</i> Pregnancy-Related Deaths, United States, 2011–2015, and Strategies for Prevention, 13 States, 2013–2017
|MMWR Morbidity and Mortality Weekly Report|2019|804
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by<i>Enterobacter</i>,<i>Citrobacter</i>or<i>Serratia</i>species: a systematic review with meta-analysis
|Journal of Antimicrobial Chemotherapy|2015|89
Neutropenia Associated with Long-Term Ceftaroline Use
|Antimicrobial Agents and Chemotherapy|2015|41
Contact and SARS-CoV-2 Infections Among College Football Athletes in the Southeastern Conference During the COVID-19 Pandemic
|JAMA Network Open|2021|19
Assessment of a Cellular Host Response Test as a Sepsis Diagnostic for Those With Suspected Infection in the Emergency Department
|Critical Care Explorations|2021|18